CMS Cuts Off 11 DME Suppliers Over $3.4B in Suspected Fraud
CMS is blocking 11 durable medical equipment suppliers from future Medicare Advantage Part C and Part D payments due to suspected fraudulent billing exceeding $3.4 billion in 2025-2026. The companies had no prior claims, used improper billing, billed for deceased beneficiaries, and supplied equipment never requested or received.
The 11 DMEPOS companies flagged by CMS had no billing history before 2025, suggesting they were newly formed or repurposed entities. Their claims included billing for equipment for deceased beneficiaries and supplying items never requested or received. Four of these firms had previously been banned from original Medicare, indicating they shifted to Medicare Advantage plans to continue operations.
CMS attributes its detection to advanced data analytics, which flagged patterns of improper billing. The total suspected fraudulent billing for 2025-2026 exceeds $3.4 billion. The agency is now blocking these suppliers from receiving future Medicare Advantage Part C and Part D payments, a significant enforcement action targeting a previously under-scrutinized area of private plan billing.
This action could protect Medicare Advantage beneficiaries from receiving unnecessary or fraudulent equipment and safeguard taxpayer funds. It may also signal a broader crackdown on DME fraud within private Medicare plans, which have historically faced less oversight than original Medicare. However, it could create administrative burdens for legitimate suppliers if data analytics produce false positives, though the specific evidence of deceased beneficiaries and unrequested equipment suggests deliberate misconduct. The impact is primarily financial and safety-related for seniors and the Medicare trust fund.